2, 6-diaminopyrimidin5-yl-carboxamides as syk or JAK kinases inhibitors

Details for Australian Patent Application No. 2009244897 (hide)

Owner Portola Pharmaceuticals, Inc.

Inventors Mehrotra, Mukund; Huang, Wolin; Song, Yonghong; Jia, Zhaozhong J.; Xu, Qing; Venkataramani, Chandrasekar; Bauer, Shawn M.; Pandey, Anjali; Rose, Jack, W.; Kane, Brian

Agent Davies Collison Cave

Pub. Number AU-A-2009244897

PCT Pub. Number WO2009/136995

Priority 61/045,499 16.04.08 US; 61/120,348 05.12.08 US; 61/120,346 05.12.08 US; 61/045,406 16.04.08 US

Filing date 16 April 2009

Wipo publication date 12 November 2009

International Classifications

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 407/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

11 November 2010 PCT application entered the National Phase

  PCT publication WO2009/136995 Priority application(s): WO2009/136995

20 January 2011 Amendment Made

  The nature of the amendment is: Add priority details under INID (31) 61/120,341; INID 05.12.08; INID US and INID (31) 61/045,399; INID 16.04.08; INID US

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009244904-Luminescent nanostructured materials for use in electrogenerated chemiluminescence

2009244878-IL-17RA-IL-17RB antagonists and uses thereof